Back to results
US 2021/0196624 A1Published application
Implantable nanochannel delivery devices
AssigneeThe Methodist Hospital System
InventorsAlessandro Grattoni, Edward Brian Butler, Ganesh Palapattu
Life of this patent
Estimating the term…
Abstract
An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.
Claims19
An implantable device, comprising:
- a tubular body defining a first opening and a reservoir, and a nanochanneled membrane disposed within the first opening, wherein the tubular body has a length of less than 5 mm.
Dependencies are inferred from the claim text.